Prinmos CLC385 fully automated glycoglogen detection kit - Taiwan Registration f3d7c92b90bf912ad1f33309875df7ab
Access comprehensive regulatory information for Prinmos CLC385 fully automated glycoglogen detection kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f3d7c92b90bf912ad1f33309875df7ab and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
It is used in the Prinsmuth CLC385 automatic glycosylated hemoglobin analysis system to quantify glycosylated hemoglobin in vitro diagnostic test by high-pressure liquid chromatography in normal or diabetic patients.
B Hematology, pathology, and genetics
B.7470 Analysis of glycosylated hemoglobin
import
Dates and Status
Jan 05, 2006
Jan 05, 2016
May 28, 2018
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ